MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD.
暂无分享,去创建一个
J. Duyster | A. Schmitt-Graeff | M. Follo | R. Thimme | J. Finke | U. Salzer | R. Zeiser | P. Hasselblatt | D. Pfeifer | N. Stickel | G. Prinz
[1] S. Atarod,et al. MicroRNAs: The Missing Link in the Biology of Graft-Versus-Host Disease? , 2013, Front. Immunol..
[2] C. Ross,et al. Atypical E2F Dependent Dysregulation Of Cell Cycling By Microrna-142 Regulates T-Cell Responses and Experimental Graft-Versus-Host Disease , 2013 .
[3] J. Karrich,et al. MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. , 2013, Blood.
[4] Lifang Jiang,et al. miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. , 2013, The Journal of infection.
[5] D. Iliopoulos,et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. , 2013, Gastroenterology.
[6] M. Idzko,et al. The Nlrp3 inflammasome regulates acute graft-versus-host disease , 2013, The Journal of experimental medicine.
[7] F. Bazzoni,et al. Negative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b , 2013, Proceedings of the National Academy of Sciences.
[8] Ryan M. O’Connell,et al. MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice , 2013, eLife.
[9] S. Grundmann,et al. Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100. , 2013, Blood.
[10] A. Vaiopoulou,et al. Association Study of Genetic Variants in miRNAs in Patients with Inflammatory Bowel Disease: Preliminary Results , 2013, Digestive Diseases and Sciences.
[11] J. Wedemeyer,et al. MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury , 2012, EMBO molecular medicine.
[12] L. Orozco,et al. MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients. , 2012, Tissue antigens.
[13] Scott E. Smith,et al. TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] D. Baltimore,et al. miR-146a controls the resolution of T cell responses in mice , 2012, The Journal of experimental medicine.
[15] Bruce R. Blazar,et al. Advances in graft-versus-host disease biology and therapy , 2012, Nature Reviews Immunology.
[16] L. Truedsson,et al. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene , 2012, Genes and Immunity.
[17] N. Yamashita,et al. Profiling of immune‐related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation , 2012, European journal of haematology.
[18] C. McCall,et al. MicroRNA‐146a regulates both transcription silencing and translation disruption of TNF‐α during TLR4‐induced gene reprogramming , 2011, Journal of leukocyte biology.
[19] M. Caligiuri,et al. Regulation of acute graft-versus-host disease by microRNA-155. , 2010, Blood.
[20] David Baltimore,et al. Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses , 2010, Cell.
[21] F. Sarkar,et al. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. , 2010, American journal of translational research.
[22] A. Arslan,et al. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. , 2010, Gynecologic oncology.
[23] Zhiwei Wang,et al. miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.
[24] K. Akashi,et al. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. , 2009, Blood.
[25] Barbara Jarzab,et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.
[26] Christopher G. King,et al. Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity. , 2007, Blood.
[27] W. Shlomchik,et al. Graft-versus-host disease , 2007, Nature Reviews Immunology.
[28] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.
[29] P. Lipsky,et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.
[30] Christopher H Contag,et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. , 2006, Blood.
[31] D. Jain,et al. Target Antigens Determine Graft-versus-Host Disease Phenotype , 2004, The Journal of Immunology.
[32] Zhijian J. Chen,et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.
[33] C. Fathman,et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.
[34] M. V. D. van den Brink,et al. Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. , 2003, Blood.
[35] J. Crawford,et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. , 2001, The Journal of clinical investigation.
[36] J. Crawford,et al. Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia , 1999 .
[37] R. Storb,et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. , 1974, Transplantation proceedings.
[38] J. Mary,et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. , 2004, Blood.
[39] J. Crawford,et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. , 1999, The Journal of clinical investigation.
[40] M. Remberger,et al. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. , 1995, Bone marrow transplantation.
[41] P. Linsley,et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.